JP2019524732A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524732A5
JP2019524732A5 JP2019501630A JP2019501630A JP2019524732A5 JP 2019524732 A5 JP2019524732 A5 JP 2019524732A5 JP 2019501630 A JP2019501630 A JP 2019501630A JP 2019501630 A JP2019501630 A JP 2019501630A JP 2019524732 A5 JP2019524732 A5 JP 2019524732A5
Authority
JP
Japan
Prior art keywords
methyl
thiazol
methoxy
methylquinoxalin
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524732A (ja
JP6903732B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041880 external-priority patent/WO2018013776A1/en
Publication of JP2019524732A publication Critical patent/JP2019524732A/ja
Publication of JP2019524732A5 publication Critical patent/JP2019524732A5/ja
Application granted granted Critical
Publication of JP6903732B2 publication Critical patent/JP6903732B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501630A 2016-07-14 2017-07-13 Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物 Active JP6903732B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662362121P 2016-07-14 2016-07-14
US62/362,121 2016-07-14
PCT/US2017/041880 WO2018013776A1 (en) 2016-07-14 2017-07-13 Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors

Publications (3)

Publication Number Publication Date
JP2019524732A JP2019524732A (ja) 2019-09-05
JP2019524732A5 true JP2019524732A5 (enExample) 2020-08-06
JP6903732B2 JP6903732B2 (ja) 2021-07-14

Family

ID=59384259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501630A Active JP6903732B2 (ja) 2016-07-14 2017-07-13 Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物

Country Status (7)

Country Link
US (3) US20190315774A1 (enExample)
EP (1) EP3484894B1 (enExample)
JP (1) JP6903732B2 (enExample)
KR (1) KR102468661B1 (enExample)
CN (1) CN109689664B (enExample)
ES (1) ES2823127T3 (enExample)
WO (1) WO2018013776A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689664B (zh) 2016-07-14 2022-04-15 百时美施贵宝公司 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物
WO2018013774A1 (en) 2016-07-14 2018-01-18 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
EP3484874B1 (en) * 2016-07-14 2020-04-29 Bristol-Myers Squibb Company Monocyclic heteroaryl substituted compounds
CN109689649B (zh) 2016-07-14 2022-07-19 百时美施贵宝公司 经二环杂芳基取代的化合物
CN111440146B (zh) * 2020-05-15 2022-10-21 中国药科大学 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
CN117285527A (zh) * 2023-09-25 2023-12-26 中国药科大学 一种噌啉类par4拮抗剂及其医药应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
TW279162B (enExample) * 1991-09-26 1996-06-21 Mitsubishi Chem Corp
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6387942B2 (en) * 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
US20050272784A1 (en) 2004-05-07 2005-12-08 Xiaobing Li Inhibitors of bacterial Type III protein secretion systems
CN101365696A (zh) 2004-07-28 2009-02-11 Irm责任有限公司 作为类固醇激素核受体调节剂的化合物和组合物
JP2008526980A (ja) 2005-01-14 2008-07-24 ジェネラブズ テクノロジーズ インコーポレーティッド ウイルス感染症を治療するためのインドール誘導体
WO2007149395A2 (en) 2006-06-20 2007-12-27 Amphora Discovery Corporation 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer
RU2424233C2 (ru) 2006-06-29 2011-07-20 Ф.Хоффманн-Ля Рош Аг Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
WO2008073451A2 (en) 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
CN101983384A (zh) 2007-11-30 2011-03-02 葛兰素史密斯克莱有限责任公司 脯氨酰羟化酶抑制剂
US8685970B2 (en) 2008-05-01 2014-04-01 GlaxoSmithKline, LLC Quinolines and related analogs as sirtuin modulators
AU2009248774B2 (en) 2008-05-23 2012-05-31 Novartis Ag Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
JP5631310B2 (ja) 2008-07-23 2014-11-26 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 三環式ピラゾロピリジンキナーゼ阻害剤
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
US9394297B2 (en) 2012-02-28 2016-07-19 Amgen Inc. Amides as pim inhibitors
ES2625029T3 (es) * 2012-04-26 2017-07-18 Bristol-Myers Squibb Company Derivados del imidazotiadiazol como inhibidores del receptor 4 activado por proteasa (Par4) para el tratamiento de la agregación de plaquetas
BR112014026651A8 (pt) * 2012-04-26 2018-01-16 Bristol Myers Squibb Co derivados de imidazotiadiazol e de imidazopiridazina como inibidores do receptor ativado por proteases 4 (par4) para o tratamento de agregação plaquetária
LT3632919T (lt) 2012-04-26 2023-02-27 Bristol-Myers Squibb Company Imidazotiadiazolo ir imidazopirazino dariniai, kaip proteazės aktyvuoto receptoriaus 4 (par4) inhibitoriai, skirti trombocitų agregacijos gydymui
WO2015077550A1 (en) * 2013-11-22 2015-05-28 University Of Kentucky Research Foundation Arylquinoline and analog compounds and use thereof to treat cancer
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US10238638B2 (en) 2015-02-26 2019-03-26 Universite De Montreal Benzothiazole and benzothiophene compounds
ES2929208T3 (es) 2015-02-26 2022-11-25 Univ Montreal Compuestos de imidazotiadiazol como inhibidores de PAR4
JP2018525371A (ja) * 2015-07-30 2018-09-06 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company アリール置換された二環式ヘテロアリール化合物
CN109689649B (zh) 2016-07-14 2022-07-19 百时美施贵宝公司 经二环杂芳基取代的化合物
EP3484874B1 (en) 2016-07-14 2020-04-29 Bristol-Myers Squibb Company Monocyclic heteroaryl substituted compounds
WO2018013774A1 (en) * 2016-07-14 2018-01-18 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
CN109689664B (zh) 2016-07-14 2022-04-15 百时美施贵宝公司 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物

Similar Documents

Publication Publication Date Title
JP2019524732A5 (enExample)
JP2019528247A5 (enExample)
JP4638355B2 (ja) チアゾール誘導体
US8129394B2 (en) Heteroaryl-substituted imidazole compounds and uses thereof
US20130109682A1 (en) Cyclic ether compounds useful as kinase inhibitors
US8865732B2 (en) Heterocyclic compounds and uses thereof
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
AR073900A1 (es) Compuestos de espiro-oxindol y su uso como agentes terapeuticos.
JP2020527560A5 (enExample)
US9181272B2 (en) Aldosterone synthase inhibitors
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
RU2507204C2 (ru) Положительные аллостерические модуляторы м1-рецепторов на основе пираниларилметилбензохиназолинона
CA3118934A1 (en) Pyridazinone compounds and uses thereof
RU2020124138A (ru) Производные аминопиридина в качестве ингибиторов фосфатидилинозитолфосфаткиназы
RU2017120859A (ru) Замещенные мостиковые аналоги мочевины в качестве модуляторов сиртуина
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
JP2010524970A5 (enExample)
JP2015528022A5 (enExample)
JP2013545744A5 (enExample)
JP2018530591A5 (enExample)
EP2909193A1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
JP2018524338A5 (enExample)
JP2019521153A5 (enExample)
JP2019505595A5 (enExample)